BIG’s Annual Report 2017 now available

Intro text: 

Brussels, Belgium, 27 June 2018. The last 5 years, more than 94% of BIG's income was invested in breast cancer research. What are BIG's realisations in 2017?

The Breast International Group (BIG) is pleased to present her latest Annual Report and is very proud of the continuous dedication and hard work of BIG’s now 59 collaborative member groups, which represent an impressive network of more than 10,000 breast cancer experts worldwide.

The Annual Report highlights both some of BIG member groups’ joint and individual activities. These pages also give a flavour of BIG’s fundraising events and corporate partnerships established throughout the past year. Finally, an overview of the current clinical studies and research programmes run within the BIG network is presented, as well as BIG’s financial statements.

By working together, we contribute to our mission to facilitate breast cancer research internationally and find better treatments and cures for patients around the world. We know that breast cancer is not one but multiple diseases, and while individual or national research initiatives on more personalised treatments are numerous, today more than ever, BIG plays a critical role in mobilising global collaboration, which is crucial to generating meaningful study results.

We wish to extend our heartfelt thanks to all our member groups, partners, supporters, donors, fundraisers and staff for their tireless determination to help advance breast cancer research and treatment. Everything that we achieve is possible because we do it together.

And, just as importantly, we wish to thank and honour the 1000s of patients who participate in our trials and work with us to develop tomorrow’s cures.

Together we have the opportunity to make a real difference in patients’ lives, both today and in the future.

* Mandatory fields
Baker street 11, 1000 Brussels
Please define to which of BIG's departments we may send your request (if applicable).

BIG against breast cancer - Annual Report 2017

Blvd de Waterloo 76
1000 Brussels